JDRF Blog

There are 5 item(s) tagged with the keyword "Clinical Trials".

1. Sernova and JDRF Announce Funding of Joint Research Collaboration to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes

$2.45 million USD awarded to advance Sernova’s Cell Pouch System(TM) (CPS) technologies in a US FDA Clinical Trial with Initiation Scheduled for the Second Half of 2016


2. Alberta Site Currently Recruiting for ViaCyte Inc. Clinical Trial

The University of Alberta is currently recruiting for its highly anticipated encapsulation trial located in Edmonton, Canada. 


3. Stem cells show promise for reversing Type 2 diabetes

Scientists at the University of British Columbia and BetaLogics, part of Janssen Research & Development, LLC have shown for the first time that Type 2 diabetes can be effectively treated with a combination of specially-cultured stem cells and conventional diabetes drugs.


4. ViaCyte Receives Clearance from Health Canada for Diabetes Clinical Trial

ViaCyte, Inc., a privately-held regenerative medicine company with the first stem cell-derived islet replacement therapy for the treatment of diabetes in clinical trials, has received a No Objection Letter from Health Canada providing clearance to proceed with sites in Canada for the Compa...


5. JDRF CCTN

JDRF Canadian Clinical Trial Network (JDRF CCTN) is a groundbreaking effort to accelerate solutions for the management, care, and cure of type 1 diabetes (T1D).


Lets turn type one into type none